Biznesradar bez reklam? Sprawdź BR Plus
Raporty finansowe: Rachunek zysków i strat
RVU (RYVU)
53.50+0.50(+0.94%)
RYVU THERAPEUTICS SPÓŁKA AKCYJNA
GPW - Akcje - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
TENDENCJE POZYTYWNE
Przychody ze sprzedaży: wzrost o 38.82% r/r |
TENDENCJE NEGATYWNE
Zysk ze sprzedaży: spadek o 28.39% r/r |
Zysk operacyjny (EBIT): spadek o 24.13% r/r |
EBITDA: spadek o 28.65% r/r |
Zysk przed opodatkowaniem: spadek o 10.11% r/r |
Zysk netto: spadek o 10.24% r/r |
dane w tys. PLN
2010/Q1 (mar 10) | 2011/Q1 (mar 11) | 2012/Q1 (mar 12) | 2013/Q1 (mar 13) | 2014/Q1 (mar 14) | 2015/Q1 (mar 15) | 2016/Q1 (mar 16) | 2017/Q1 (mar 17) | 2018/Q1 (mar 18) | 2019/Q1 (mar 19) | 2020/Q1 (mar 20) | 2021/Q1 (mar 21) | 2022/Q1 (mar 22) | 2023/Q1 (mar 23) | 2024/Q1 (mar 24) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Data publikacji | 2010-05-14 | 2011-05-13 | 2012-05-15 | 2013-05-15 | 2014-05-13 | 2015-05-12 | 2016-05-12 | 2017-05-30 | 2018-05-22 | 2019-05-22 | 2020-06-10 | 2021-05-12 | 2022-05-18 | 2023-05-16 | 2024-05-15 | |
Przychody ze sprzedaży | 1 070 k/k -65.97%~sektor -72.21% | 1 974 r/r +84.49%~sektor +25.37% k/k -76.54%~sektor -74.63% | 2 059 r/r +4.31%~sektor +15.15% k/k -78.07%~sektor -74.64% | 2 289 r/r +11.17%~sektor +8.75% k/k -75.53%~sektor -73.69% | 4 919 r/r +114.90%~sektor -4.70% k/k -62.84%~sektor -75.78% | 12 027 r/r +144.50%~sektor +1.37% k/k -58.33%~sektor -76.08% | 13 355 r/r +11.04%~sektor +11.04% k/k -76.04%~sektor -75.30% | 17 168 r/r +28.55%~sektor +4.72% k/k -71.48%~sektor -76.03% | 23 179 r/r +35.01%~sektor +8.27% k/k -78.01%~sektor -73.71% | 29 800 r/r +28.56%~sektor +0.49% k/k -72.72%~sektor -75.41% | 13 515 r/r -54.65%~sektor +14.30% k/k -68.25%~sektor -72.14% | 6 553 r/r -51.51%~sektor -2.57% k/k -82.27%~sektor -73.96% | 6 982 r/r +6.55%~sektor +8.99% k/k -81.17%~sektor -75.23% | 18 316 r/r +162.33%~sektor +14.62% k/k -73.24%~sektor -74.05% | 25 426 r/r +38.82%~sektor -2.40% k/k -62.22%~sektor -75.53% | |
Techniczny koszt wytworzenia produkcji sprzedanej | 2 442 k/k -65.06%~sektor -73.02% | 4 149 r/r +69.90%~sektor +26.79% k/k -69.56%~sektor -71.74% | 4 827 r/r +16.34%~sektor +22.36% k/k -75.40%~sektor -75.22% | 4 952 r/r +2.59%~sektor +5.98% k/k -77.70%~sektor -76.14% | 7 115 r/r +43.68%~sektor -4.59% k/k -70.59%~sektor -75.38% | 10 417 r/r +46.41%~sektor -0.18% k/k -71.25%~sektor -73.87% | 15 211 r/r +46.02%~sektor +14.82% k/k -70.02%~sektor -73.53% | 18 579 r/r +22.14%~sektor +9.66% k/k -71.16%~sektor -74.98% | 23 496 r/r +26.47%~sektor -4.24% k/k -73.96%~sektor -77.05% | 36 450 r/r +55.13%~sektor +3.93% k/k -69.48%~sektor -75.39% | 18 580 r/r -49.03%~sektor +5.93% k/k -79.96%~sektor -72.42% | 22 300 r/r +20.02%~sektor +6.81% k/k -69.44%~sektor -72.93% | 33 810 r/r +51.61%~sektor +29.32% k/k -70.68%~sektor -72.63% | 35 840 r/r +6.00%~sektor +14.27% k/k -74.38%~sektor -75.41% | 47 925 r/r +33.72%~sektor +6.21% k/k -70.96%~sektor -74.91% | |
Koszty sprzedaży | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 k/k -100.00%~sektor -77.50% | 0 | 0 | 0 | 0 | |
Koszty ogólnego zarządu | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 k/k -100.00%~sektor -76.48% | 0 | 0 | 0 | 0 | |
Zysk ze sprzedaży | -1 372 k/k +64.32%~sektor -53.14% | -2 175 r/r -58.53%~sektor +25.07% k/k +58.32%~sektor -59.61% | -2 768 r/r -27.26%~sektor -11.16% k/k +72.95%~sektor -67.60% | -2 663 r/r +3.79%~sektor +16.74% k/k +79.28%~sektor -55.21% | -2 196 r/r +17.54%~sektor -26.48% k/k +79.96%~sektor -70.62% | 1 610 r/r +173.32%~sektor -11.84% k/k +121.85%~sektor -71.46% | -1 856 r/r -215.28%~sektor +19.81% k/k -137.22%~sektor +53.99% | -1 411 r/r +23.98%~sektor -69.72% k/k +66.57%~sektor +50.63% | -317 r/r +77.53%~sektor +66.39% k/k -102.09%~sektor +67.84% | -6 650 r/r -1997.79%~sektor -19.92% k/k +34.80%~sektor +56.69% | -5 065 r/r +23.83%~sektor +37.84% k/k +93.42%~sektor +73.71% | -15 747 r/r -210.90%~sektor +3.33% k/k +56.29%~sektor -37.72% | -26 828 r/r -70.37%~sektor -59.59% k/k +65.71%~sektor +47.80% | -17 524 r/r +34.68%~sektor 0.00% k/k +75.48%~sektor +70.14% | -22 499 r/r -28.39%~sektor -13.25% k/k +76.98%~sektor +68.14% | |
Pozostałe przychody operacyjne | k/k -100.00%~sektor -75.76% | k/k -100.00%~sektor -91.58% | k/k -100.00%~sektor -89.44% | 1 707 k/k -74.48%~sektor -78.95% | 2 748 r/r +60.98%~sektor 0.00% k/k -68.99%~sektor -75.39% | 79 r/r -97.13%~sektor -47.92% k/k -99.38%~sektor -90.53% | 124 r/r +56.96%~sektor -37.56% k/k -64.37%~sektor -89.54% | 9 673 r/r +7700.81%~sektor +97.40% k/k +48.36%~sektor -76.58% | 141 r/r -98.54%~sektor +22.87% k/k -69.35%~sektor -78.26% | 357 r/r +153.19%~sektor +15.23% k/k -59.34%~sektor -71.58% | 98 r/r -72.55%~sektor -33.95% k/k -99.69%~sektor -80.32% | 93 r/r -5.10%~sektor -32.29% k/k -75.33%~sektor -82.32% | 111 r/r +19.35%~sektor +26.90% k/k -74.19%~sektor -75.69% | -545 r/r -590.99%~sektor -21.54% k/k +92.07%~sektor -82.67% | 76 r/r +113.94%~sektor -14.29% k/k +102.64%~sektor -87.64% | |
Pozostałe koszty operacyjne | k/k -100.00%~sektor -99.65% | k/k -100.00%~sektor -94.35% | k/k -100.00%~sektor -90.36% | 15 k/k -84.54%~sektor -79.55% | 1 r/r -93.33%~sektor -69.50% k/k -96.88%~sektor -90.77% | 568 r/r +56700.00%~sektor -26.23% k/k +971.70%~sektor -94.41% | 831 r/r +46.30%~sektor +14.71% k/k -74.52%~sektor -80.10% | 696 r/r -16.25%~sektor -15.30% k/k -80.19%~sektor -91.17% | 698 r/r +0.29%~sektor +21.78% k/k -76.63%~sektor -83.97% | 1 310 r/r +87.68%~sektor -9.18% k/k -69.46%~sektor -84.49% | 0 r/r -100.00%~sektor +30.95% k/k -100.00%~sektor -86.62% | 1 k/k -97.87%~sektor -90.68% | 37 r/r +3600.00%~sektor -4.01% k/k -28.85%~sektor -90.16% | 34 r/r -8.11%~sektor +9.20% k/k -60.92%~sektor -86.30% | 49 r/r +44.12%~sektor +32.76% k/k -85.06%~sektor -86.63% | |
Zysk operacyjny (EBIT) | -1 265 k/k +53.98%~sektor -60.82% | -1 292 r/r -2.13%~sektor +20.96% k/k +56.72%~sektor -73.29% | -1 578 r/r -22.14%~sektor -8.94% k/k +75.88%~sektor -66.51% | -971 r/r +38.47%~sektor +36.56% k/k +84.50%~sektor -51.17% | 551 r/r +156.75%~sektor -32.50% k/k +125.91%~sektor -70.96% | 1 121 r/r +103.45%~sektor -17.77% k/k -78.74%~sektor -72.49% | -2 563 r/r -328.64%~sektor +18.66% k/k -223.64%~sektor +53.10% | 7 566 r/r +395.20%~sektor -66.64% k/k +723.23%~sektor +68.19% | -874 r/r -111.55%~sektor +50.74% k/k -106.92%~sektor +37.03% | -7 603 r/r -769.91%~sektor +6.63% k/k +44.14%~sektor +57.07% | -4 967 r/r +34.67%~sektor +35.16% k/k +89.00%~sektor +77.12% | -15 655 r/r -215.18%~sektor -5.42% k/k +56.14%~sektor -38.07% | -26 754 r/r -70.90%~sektor -38.32% k/k +65.64%~sektor -69.41% | -18 103 r/r +32.34%~sektor +26.61% k/k +76.92%~sektor +63.55% | -22 472 r/r -24.13%~sektor -24.94% k/k +77.74%~sektor +48.50% | |
Przychody finansowe | k/k -100.00%~sektor -96.52% | k/k -100.00%~sektor -93.98% | k/k -100.00%~sektor -80.16% | 28 k/k -88.33%~sektor -69.14% | 38 r/r +35.71%~sektor +29.41% k/k +5.56%~sektor -80.96% | 300 r/r +689.47%~sektor +73.96% k/k -20.21%~sektor -66.56% | 157 r/r -47.67%~sektor -47.67% k/k -81.40%~sektor -57.38% | 20 r/r -87.26%~sektor -7.24% k/k -98.23%~sektor -72.75% | 538 r/r +2590.00%~sektor +18.56% k/k +478.49%~sektor -84.15% | 648 r/r +20.45%~sektor -24.39% k/k -69.61%~sektor -64.07% | 435 r/r -32.87%~sektor +36.90% k/k -95.44%~sektor -72.97% | 671 r/r +54.25%~sektor -58.92% k/k +206.39%~sektor -58.54% | 205 r/r -69.45%~sektor -25.08% k/k -66.06%~sektor -66.06% | 2 117 r/r +932.68%~sektor +680.73% k/k +84.89%~sektor -25.42% | 3 813 r/r +80.11%~sektor +26.32% k/k -72.44%~sektor -74.55% | |
Koszty finansowe | k/k -100.00%~sektor -91.39% | k/k -100.00%~sektor -86.15% | k/k -100.00%~sektor -84.08% | 12 k/k -92.68%~sektor -78.37% | 3 r/r -75.00%~sektor -37.17% k/k -98.72%~sektor -86.82% | 140 r/r +4566.67%~sektor +36.30% k/k -36.65%~sektor -71.38% | 115 r/r -17.86%~sektor +5.59% k/k +19.79%~sektor -79.00% | 837 r/r +627.83%~sektor -8.42% k/k +354.89%~sektor -76.47% | 490 r/r -41.46%~sektor -41.46% k/k -76.09%~sektor -84.14% | 180 r/r -63.27%~sektor +4.41% k/k -44.10%~sektor -77.62% | 202 r/r +12.22%~sektor +40.11% k/k -52.47%~sektor -68.94% | 142 r/r -29.70%~sektor -19.06% k/k -71.66%~sektor -76.62% | 32 r/r -77.46%~sektor +10.71% k/k -92.76%~sektor -71.99% | 1 611 r/r +4934.38%~sektor +44.62% k/k -16.01%~sektor -72.38% | 717 r/r -55.49%~sektor -14.85% k/k -85.65%~sektor -77.84% | |
Pozostałe przychody (koszty) | -40 | 0 r/r +100.00%~sektor +86.87% k/k +100.00%~sektor +100.00% | 0 | 0 | 0 | 20 787 | 0 r/r -100.00%~sektor -100.00% k/k -100.00%~sektor -6.89% | 0 | 1 902 k/k -64.54%~sektor +67.78% | -2 r/r -100.11%~sektor -3.14% k/k -100.70%~sektor +99.96% | 0 r/r +100.00%~sektor +100.00% | 0 | ||||
Zysk z działalności gospodarczej | -1 365 k/k +51.32%~sektor -58.81% | -1 494 r/r -9.45%~sektor +21.35% k/k +52.69%~sektor -62.22% | -1 659 r/r -11.04%~sektor +2.83% k/k +62.04%~sektor -18.59% | -996 r/r +39.96%~sektor +39.96% k/k +83.90%~sektor -49.30% | 586 r/r +158.84%~sektor -19.47% k/k +124.78%~sektor -75.55% | 1 281 r/r +118.60%~sektor -17.25% k/k -76.40%~sektor -64.86% | -2 521 r/r -296.80%~sektor +15.65% k/k -189.37%~sektor +55.02% | 6 749 r/r +367.71%~sektor -63.11% k/k +2637.22%~sektor +72.50% | 19 961 r/r +195.76%~sektor +67.55% k/k +86.85%~sektor +75.21% | -7 135 r/r -135.74%~sektor +18.44% k/k -179.40%~sektor +48.48% | -4 734 r/r +33.65%~sektor +33.65% k/k +86.86%~sektor +80.44% | -13 224 r/r -179.34%~sektor +8.14% k/k +56.81%~sektor -25.06% | -26 583 r/r -101.02%~sektor -57.54% k/k +65.66%~sektor +45.94% | -17 597 r/r +33.80%~sektor +25.63% k/k +77.78%~sektor +77.78% | -19 376 r/r -10.11%~sektor -16.10% k/k +78.96%~sektor +45.04% | |
Wynik zdarzeń nadzwyczajnych | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Zysk przed opodatkowaniem | -1 365 k/k +51.32%~sektor -58.81% | -1 494 r/r -9.45%~sektor +21.35% k/k +52.69%~sektor -62.22% | -1 659 r/r -11.04%~sektor +2.83% k/k +62.04%~sektor -18.59% | -996 r/r +39.96%~sektor +39.96% k/k +83.90%~sektor -49.30% | 586 r/r +158.84%~sektor -19.47% k/k +124.78%~sektor -75.55% | 1 281 r/r +118.60%~sektor -17.25% k/k -76.40%~sektor -64.86% | -2 521 r/r -296.80%~sektor +15.65% k/k -189.37%~sektor +55.02% | 6 749 r/r +367.71%~sektor -63.11% k/k +2637.22%~sektor +72.50% | 19 961 r/r +195.76%~sektor +67.55% k/k +86.85%~sektor +75.21% | -7 135 r/r -135.74%~sektor +18.44% k/k -179.40%~sektor +48.48% | -4 734 r/r +33.65%~sektor +33.65% k/k +86.86%~sektor +80.44% | -13 224 r/r -179.34%~sektor +8.14% k/k +56.81%~sektor -25.06% | -26 583 r/r -101.02%~sektor -57.54% k/k +65.66%~sektor +45.94% | -17 597 r/r +33.80%~sektor +25.63% k/k +77.78%~sektor +77.78% | -19 376 r/r -10.11%~sektor -16.10% k/k +78.96%~sektor +45.04% | |
Zysk (strata) netto z działalności zaniechanej | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Zysk netto | -1 106 k/k +63.68%~sektor -54.63% | -1 269 r/r -14.74%~sektor +25.01% k/k +35.71%~sektor -69.42% | -1 659 r/r -30.73%~sektor -14.36% k/k +62.63%~sektor -36.81% | -996 r/r +39.96%~sektor +35.85% k/k +84.51%~sektor -49.91% | 568 r/r +157.03%~sektor -24.41% k/k +123.82%~sektor -61.37% | 1 276 r/r +124.65%~sektor -22.57% k/k -78.19%~sektor -50.24% | -2 523 r/r -297.73%~sektor +5.92% k/k -140.48%~sektor +64.37% | 5 396 r/r +313.87%~sektor -80.60% k/k +100.97%~sektor +62.66% | 19 894 r/r +268.68%~sektor +60.58% k/k +195.51%~sektor +76.71% | -7 353 r/r -136.96%~sektor +13.66% k/k -924.33%~sektor +48.48% | -4 307 r/r +41.43%~sektor +28.27% k/k +88.04%~sektor +73.96% | -13 563 r/r -214.91%~sektor +8.87% k/k +57.20%~sektor -1.69% | -26 536 r/r -95.65%~sektor -50.36% k/k +65.78%~sektor +45.94% | -17 597 r/r +33.69%~sektor +19.23% k/k +79.00%~sektor +78.79% | -19 399 r/r -10.24%~sektor -49.50% k/k +78.94%~sektor +49.37% | |
Zysk netto akcjonariuszy jednostki dominującej | -1 106 k/k +63.68%~sektor -54.63% | -1 269 r/r -14.74%~sektor +24.00% k/k +35.71%~sektor -69.42% | -1 659 r/r -30.73%~sektor -17.70% k/k +62.63%~sektor -36.81% | -996 r/r +39.96%~sektor +35.85% k/k +84.51%~sektor -48.69% | 568 r/r +157.03%~sektor -22.74% k/k +123.82%~sektor -62.45% | 1 276 r/r +124.65%~sektor -27.92% k/k -78.19%~sektor -54.98% | -2 523 r/r -297.73%~sektor -17.49% k/k -140.24%~sektor +64.37% | 5 244 r/r +307.85%~sektor -80.48% k/k +92.79%~sektor +62.62% | 19 963 r/r +280.68%~sektor +57.08% k/k +211.58%~sektor +76.71% | -7 548 r/r -137.81%~sektor +13.66% k/k -7020.75%~sektor +48.48% | -4 307 r/r +42.94%~sektor +28.70% k/k +88.04%~sektor +71.64% | -13 563 r/r -214.91%~sektor +8.70% k/k +57.20%~sektor -26.67% | -26 536 r/r -95.65%~sektor -50.36% k/k +65.78%~sektor +45.94% | -17 597 r/r +33.69%~sektor +33.69% k/k +79.00%~sektor +78.79% | -19 399 r/r -10.24%~sektor -49.50% k/k +78.94%~sektor +49.37% | |
EBITDA | -920 k/k +57.37%~sektor -63.14% | -912 r/r +0.87%~sektor +36.95% k/k +42.42%~sektor -73.61% | -1 184 r/r -29.82%~sektor -8.61% k/k +78.02%~sektor -68.29% | -486 r/r +58.95%~sektor +52.98% k/k +89.45%~sektor -57.00% | 1 108 r/r +327.98%~sektor -13.86% k/k +2562.22%~sektor -72.90% | 1 893 r/r +70.85%~sektor -21.59% k/k -75.18%~sektor -73.40% | -1 712 r/r -190.44%~sektor +37.56% k/k -131.09%~sektor -37.31% | 8 561 r/r +600.06%~sektor -36.65% k/k +256.26%~sektor +49.02% | 821 r/r -90.41%~sektor +55.70% k/k -95.41%~sektor -46.92% | -3 299 r/r -501.83%~sektor +12.95% k/k +38.75%~sektor +35.29% | -2 517 r/r +23.70%~sektor +36.13% k/k +93.22%~sektor +67.81% | -12 766 r/r -407.19%~sektor -3.42% k/k +45.30%~sektor -46.23% | -23 379 r/r -83.13%~sektor -25.82% k/k +64.20%~sektor -70.85% | -15 321 r/r +34.47%~sektor +28.65% k/k +76.62%~sektor -5.45% | -19 710 r/r -28.65%~sektor -28.65% k/k +78.09%~sektor -36.02% |
Dane pozyskiwane są ze skonsolidowanych sprawozdań finansowych lub jednostkowych, jeśli spółka tylko takie publikuje.
Dane kwartalne RZiS oraz CashFlow obliczne są na podstawie publikowanych danych skumulowanych.
Dynamika zmian dla sektora obliczana jest w oparciu o medianę.
Dane w tys. PLN
Dane kwartalne RZiS oraz CashFlow obliczne są na podstawie publikowanych danych skumulowanych.
Dynamika zmian dla sektora obliczana jest w oparciu o medianę.
Dane w tys. PLN
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
ISIN: | PLSELVT00013 |
---|---|
Data debiutu: | 14.07.2011 |
Liczba akcji: | 23 120 148 |
Kapitalizacja: | 1 236 927 918 |
Enterprise Value: | 1 133 669 918 |
Branża: | Biotechnologia |
Ryvu Therapeutics jest biotechnologiczną spółką badawczo-rozwojową. Działalność spółki obejmuje odkrywanie i rozwoju leków m.in. w obszarach... Ryvu Therapeutics jest biotechnologiczną spółką badawczo-rozwojową. Działalność spółki obejmuje odkrywanie i rozwoju leków m.in. w obszarach onkologicznym, chorób nowotworowych oraz chorób autoimmunologicznych. Spółka zajmuje się również świadczeniem usług badawczo-rozwojowych z zakresu chemii, biotechnologii oraz bioinformatyki dla koncernów farmaceutycznych.
Nazwa: | RYVU THERAPEUTICS SPÓŁKA AKCYJNA |
---|---|
Adres: | ul. Leona Sternbacha 2, 30-348, Kraków, POLSKA |
CEO: | Paweł Przewięźlikowski |
NIP: | 6792942955 |
REGON: | 120515330 |
KRS: | 0000367359 |
Telefon: | +48 (12) 297 47 00 |
WWW: | https://ryvu.com/ |
Biznesradar bez reklam? Sprawdź BR Plus